Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury

John G. Cooper, Su Ji Jeong, Tammy L. McGuire, Sripadh Sharma, Wenxia Wang, Swati Bhattacharyya, John Varga, John Kessler*

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Gliosis and fibrosis after spinal cord injury (SCI) lead to formation of a scar that is an impediment to axonal regeneration. Fibrotic scarring is characterized by the accumulation of fibronectin, collagen, and fibroblasts at the lesion site. The mechanisms regulating fibrotic scarring after SCI and its effects on axonal elongation and functional recovery are not well understood. In this study, we examined the effects of eliminating an isoform of fibronectin containing the Extra Domain A domain (FnEDA) on both fibrosis and on functional recovery after contusion SCI using male and female FnEDA-null mice. Eliminating FnEDA did not reduce the acute fibrotic response but markedly diminished chronic fibrotic scarring after SCI. Glial scarring was unchanged after SCI in FnEDA-null mice. We found that FnEDA was important for the long-term stability of the assembled fibronectin matrix during both the subacute and chronic phases of SCI. Motor functional recovery was significantly improved, and there were increased numbers of axons in the lesion site compared to wildtype mice, suggesting that the chronic fibrotic response is detrimental to recovery. Our data provide insight into the mechanisms of fibrosis after SCI and suggest that disruption of fibronectin matrix stability by targeting FnEDA represents a potential therapeutic strategy for promoting recovery after SCI.

Original languageEnglish (US)
Pages (from-to)60-68
Number of pages9
JournalNeurobiology of Disease
Volume116
DOIs
StatePublished - Aug 1 2018

Fingerprint

Spinal Cord Injuries
Fibronectins
Cicatrix
Fibrosis
Gliosis
Contusions
Neuroglia
Axons
Regeneration
Protein Isoforms
Collagen
Fibroblasts

Keywords

  • Fibronectin
  • Fibronectin EDA
  • Fibrosis
  • Gliosis
  • Matrix
  • Scarring
  • Spinal cord injury

ASJC Scopus subject areas

  • Neurology

Cite this

Cooper, John G. ; Jeong, Su Ji ; McGuire, Tammy L. ; Sharma, Sripadh ; Wang, Wenxia ; Bhattacharyya, Swati ; Varga, John ; Kessler, John. / Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury. In: Neurobiology of Disease. 2018 ; Vol. 116. pp. 60-68.
@article{8151f5df20f140fba601c814711ed664,
title = "Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury",
abstract = "Gliosis and fibrosis after spinal cord injury (SCI) lead to formation of a scar that is an impediment to axonal regeneration. Fibrotic scarring is characterized by the accumulation of fibronectin, collagen, and fibroblasts at the lesion site. The mechanisms regulating fibrotic scarring after SCI and its effects on axonal elongation and functional recovery are not well understood. In this study, we examined the effects of eliminating an isoform of fibronectin containing the Extra Domain A domain (FnEDA) on both fibrosis and on functional recovery after contusion SCI using male and female FnEDA-null mice. Eliminating FnEDA did not reduce the acute fibrotic response but markedly diminished chronic fibrotic scarring after SCI. Glial scarring was unchanged after SCI in FnEDA-null mice. We found that FnEDA was important for the long-term stability of the assembled fibronectin matrix during both the subacute and chronic phases of SCI. Motor functional recovery was significantly improved, and there were increased numbers of axons in the lesion site compared to wildtype mice, suggesting that the chronic fibrotic response is detrimental to recovery. Our data provide insight into the mechanisms of fibrosis after SCI and suggest that disruption of fibronectin matrix stability by targeting FnEDA represents a potential therapeutic strategy for promoting recovery after SCI.",
keywords = "Fibronectin, Fibronectin EDA, Fibrosis, Gliosis, Matrix, Scarring, Spinal cord injury",
author = "Cooper, {John G.} and Jeong, {Su Ji} and McGuire, {Tammy L.} and Sripadh Sharma and Wenxia Wang and Swati Bhattacharyya and John Varga and John Kessler",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.nbd.2018.04.014",
language = "English (US)",
volume = "116",
pages = "60--68",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury. / Cooper, John G.; Jeong, Su Ji; McGuire, Tammy L.; Sharma, Sripadh; Wang, Wenxia; Bhattacharyya, Swati; Varga, John; Kessler, John.

In: Neurobiology of Disease, Vol. 116, 01.08.2018, p. 60-68.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury

AU - Cooper, John G.

AU - Jeong, Su Ji

AU - McGuire, Tammy L.

AU - Sharma, Sripadh

AU - Wang, Wenxia

AU - Bhattacharyya, Swati

AU - Varga, John

AU - Kessler, John

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Gliosis and fibrosis after spinal cord injury (SCI) lead to formation of a scar that is an impediment to axonal regeneration. Fibrotic scarring is characterized by the accumulation of fibronectin, collagen, and fibroblasts at the lesion site. The mechanisms regulating fibrotic scarring after SCI and its effects on axonal elongation and functional recovery are not well understood. In this study, we examined the effects of eliminating an isoform of fibronectin containing the Extra Domain A domain (FnEDA) on both fibrosis and on functional recovery after contusion SCI using male and female FnEDA-null mice. Eliminating FnEDA did not reduce the acute fibrotic response but markedly diminished chronic fibrotic scarring after SCI. Glial scarring was unchanged after SCI in FnEDA-null mice. We found that FnEDA was important for the long-term stability of the assembled fibronectin matrix during both the subacute and chronic phases of SCI. Motor functional recovery was significantly improved, and there were increased numbers of axons in the lesion site compared to wildtype mice, suggesting that the chronic fibrotic response is detrimental to recovery. Our data provide insight into the mechanisms of fibrosis after SCI and suggest that disruption of fibronectin matrix stability by targeting FnEDA represents a potential therapeutic strategy for promoting recovery after SCI.

AB - Gliosis and fibrosis after spinal cord injury (SCI) lead to formation of a scar that is an impediment to axonal regeneration. Fibrotic scarring is characterized by the accumulation of fibronectin, collagen, and fibroblasts at the lesion site. The mechanisms regulating fibrotic scarring after SCI and its effects on axonal elongation and functional recovery are not well understood. In this study, we examined the effects of eliminating an isoform of fibronectin containing the Extra Domain A domain (FnEDA) on both fibrosis and on functional recovery after contusion SCI using male and female FnEDA-null mice. Eliminating FnEDA did not reduce the acute fibrotic response but markedly diminished chronic fibrotic scarring after SCI. Glial scarring was unchanged after SCI in FnEDA-null mice. We found that FnEDA was important for the long-term stability of the assembled fibronectin matrix during both the subacute and chronic phases of SCI. Motor functional recovery was significantly improved, and there were increased numbers of axons in the lesion site compared to wildtype mice, suggesting that the chronic fibrotic response is detrimental to recovery. Our data provide insight into the mechanisms of fibrosis after SCI and suggest that disruption of fibronectin matrix stability by targeting FnEDA represents a potential therapeutic strategy for promoting recovery after SCI.

KW - Fibronectin

KW - Fibronectin EDA

KW - Fibrosis

KW - Gliosis

KW - Matrix

KW - Scarring

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=85047100057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047100057&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2018.04.014

DO - 10.1016/j.nbd.2018.04.014

M3 - Article

VL - 116

SP - 60

EP - 68

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -